DAY 1
Omixon was exhibiting and EFI 2013 conference in Maastricht. As this conference was focusing on immunogenetics, everything was about HLA. So we were preparing very hard to be on our best shape during these few days. The opening ceremony was on Saturday evening.
Month: May 2013
Omixon is attending TCGC in San Francisco. Meet us there!
The Clinical Genome Conference (TCGC) 2013 brings together many constituencies for frank and vital discussion of the applications, questions and solutions surrounding clinical genome analysis, including scientists, physicians, diagnosticians, genetic counselors, bioinformaticists, ethicists, regulators, insurers, lawyers, and administrators.
Omixon is exhibiting at TCGC in San Francisco, from 25th to 28th June, 2013.
Our CTO, Tim Hague and Hajnalka Hejja will be there.
The Omixon App in Illumina’s genomics cloud computing and storage platform
It’s a huge pleasure to announce that BaseSpace, Illumina’s genomics cloud computing and storage platform, just became commercially available and one of the first apps was launched by Omixon. The commercial release includes a fully supported BaseSpace Apps store for quick and easy access to Illumina and third-party bioinformatics applications.
Webinar about HLA typing from NGS data
Broadcast date: 29 May 2013, Wednesday
Time: 9.00-10.00 AM PT/ 18.00-19.00 CET
Come and join our CEO, Attila Berces online in a presentation and demo of how Omixon Target HLA typing will bring you value during the analysis of NGS data.
Currently, there are 69 on-going clinical trials investigating HLA as a potential biomarker for safety or efficacy. It appears that beside being the most important marker in transplantation, HLA is becoming a more important biomarker for cancer therapeutic development as well. The analytical performance of NGS-based genetic tests highly depends on the bioinformatics software. Although the current false variant rate can be acceptable for research market, it is simply unsuitable for making clinical decisions. Omixon tailors the analysis for the sequencer, amplification method, primer kit, and the characteristics of the gene target itself. This approach results in a robust and highly accurate method to identify genetic variants.
In this webinar you will learn:
- How to reduce ambiguity and increase resolution
- How to achieve the highest accuracy
- How to use Omixon Target HLA as an HLA-typing tool
- How to increase efficiency by reducing effort, time and cost
Who should attend?
- Scientists and researchers from HLA-typing labs
- Molecular biologists working with NGS
- Medical professionals working in transplantation,oncology and immunology
- Bioinformathics working in transplantaion, oncology and immunology
Presenting: Attila Berces, PhD, CEO of Omixon Biocomputing
A live Q&A session will follow the presentation, offering you the opportunity to put forward your questions.
Reserve your webinar seat here.
Download the World’s Best Genome Browser for Free!
We are still offering the world’s best genome browser to download for free. It provides a great way to browse the genome, use it in cancer research and many other areas.
Give it a try and tell us what you think!
